Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
12.12
-0.16 (-1.30%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Medifast Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 316.93 | 385.79 | 602.46 | 1,072 | 1,599 | 1,526 |
Revenue Growth | -34.03% | -35.97% | -43.80% | -32.94% | 4.75% | 63.24% |
Gross Profit Gross Profit Growth | 219.45 | 275.19 | 444.62 | 775.85 | 1,140 | 1,128 |
Operating Income Operating Income Growth | -19.51 | -14.21 | 2.88 | 126.4 | 184.81 | 216.24 |
Net Income Net Income Growth | -25.6 | -18.67 | 2.09 | 99.42 | 143.57 | 164.03 |
Earnings Per Share EPS Growth | -2.33 | -1.70 | 0.19 | 9.10 | 12.73 | 13.89 |
EPS Growth | - | - | -97.91% | -28.52% | -8.35% | 60.02% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 169.82 | 167.27 | 162.34 | 150.04 | 87.69 | 109.54 |
Total Debt Total Debt Growth | 27.62 | 10.69 | 16.13 | 22.01 | 26.05 | 32.54 |
Net Cash (Debt) Net Cash Growth | 142.2 | 156.58 | 146.22 | 128.03 | 61.64 | 77 |
Net Cash Growth | -4.95% | 7.08% | 14.21% | 107.70% | -19.95% | -52.85% |
Net Cash Per Share Net Cash Per Share Growth | 12.89 | 14.26 | 13.34 | 11.72 | 5.47 | 6.52 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 8.79 | 6.86 | 24.48 | 147.66 | 194.57 | 94.55 |
Capital Expenditures CapEx Growth | -4.78 | -5.61 | -7.45 | -6.48 | -16.68 | -34.21 |
Free Cash Flow Free Cash Flow Growth | 4.01 | 1.25 | 17.02 | 141.17 | 177.89 | 60.34 |
Free Cash Flow Growth | - | -92.66% | -87.94% | -20.64% | 194.83% | -56.69% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 69.24% | 71.33% | 73.80% | 72.37% | 71.34% | 73.89% |
Operating Margin | -6.15% | -3.68% | 0.48% | 11.79% | 11.56% | 14.17% |
Pretax Margin | -4.41% | -1.46% | 0.63% | 12.01% | 11.51% | 14.16% |
Profit Margin | -8.08% | -4.84% | 0.35% | 9.27% | 8.98% | 10.75% |
FCF Margin | 1.27% | 0.32% | 2.83% | 13.17% | 11.13% | 3.95% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | - | - | 4.950 | 6.560 | 5.680 |
Dividend Per Share Growth | - | - | -24.54% | 15.49% | 25.66% |
Dividend Yield | 0.17% | 0.37% | 9.98% | 5.55% | 2.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 92.74 | 7.39 | 9.06 | 15.08 |
Forward PE | - | 53.77 | 38.00 | 13.05 | 9.03 | 13.75 |
P/FCF Ratio | 31.22 | 93.98 | 11.32 | 5.19 | 7.05 | 40.24 |
PS Ratio | 0.40 | 0.30 | 0.32 | 0.68 | 0.78 | 1.59 |